Upstream mitogen-activated protein kinase (MAPK)pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients

Saved in:
Bibliographic Details
Other Authors: Goldinger, Simone M. (Other) , Schulz, Carsten (Other) , Hassel, Jessica C. (Other)
Format: Article (Journal)
Language:English
Published: 2014
In: European journal of cancer
Year: 2014, Volume: 50, Issue: 2, Pages: 406-410
ISSN:1879-0852
DOI:10.1016/j.ejca.2013.09.014
Online Access:Resolving-System, Volltext: http://www.ncbi.nlm.nih.gov/pubmed/24183461
Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2013.09.014
Get full text
Author Notes:Goldinger, Simone M.; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C.; Schadendorf, Dirk; Hassel, Jessica C.; Becker, Juergen; Hauschild, Axel; Dummer, Reinhard

MARC

LEADER 00000caa a2200000 c 4500
001 1485234352
003 DE-627
005 20220811131424.0
007 cr uuu---uuuuu
008 141008s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2013.09.014  |2 doi 
035 |a (DE-627)1485234352 
035 |a (DE-576)415234352 
035 |a (DE-599)BSZ415234352 
035 |a (OCoLC)1340650509 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Upstream mitogen-activated protein kinase (MAPK)pathway inhibition  |b MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients  |c Goldinger, Simone M.; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C.; Schadendorf, Dirk; Hassel, Jessica C.; Becker, Juergen; Hauschild, Axel; Dummer, Reinhard 
264 1 |c 2014 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.10.2014 
700 1 |a Goldinger, Simone M.  |0 (DE-588)1059230828  |0 (DE-627)798164743  |0 (DE-576)415234263  |4 oth 
700 1 |a Schulz, Carsten  |0 (DE-588)1059230739  |0 (DE-627)798164573  |0 (DE-576)415234050  |4 oth 
700 1 |a Hassel, Jessica C.  |d 1975-  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 oth 
773 0 8 |i In  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 50(2014), 2, Seite 406-410  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Upstream mitogen-activated protein kinase (MAPK)pathway inhibition MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients 
773 1 8 |g volume:50  |g year:2014  |g number:2  |g pages:406-410  |g extent:5  |a Upstream mitogen-activated protein kinase (MAPK)pathway inhibition MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients 
856 4 0 |u http://www.ncbi.nlm.nih.gov/pubmed/24183461  |x Resolving-System  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1016/j.ejca.2013.09.014  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20141008 
993 |a Article 
994 |a 2014 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 8 
998 |g 1059230739  |a Schulz, Carsten  |m 1059230739:Schulz, Carsten  |d 910000  |d 911300  |e 910000PS1059230739  |e 911300PS1059230739  |k 0/910000/  |k 1/910000/911300/  |p 3 
999 |a KXP-PPN1485234352  |e 2817171136 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Goldinger","display":"Goldinger, Simone M.","given":"Simone M.","role":"oth"},{"family":"Schulz","role":"oth","given":"Carsten","display":"Schulz, Carsten"},{"role":"oth","given":"Jessica C.","display":"Hassel, Jessica C.","family":"Hassel"}],"name":{"displayForm":["Goldinger, Simone M.; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C.; Schadendorf, Dirk; Hassel, Jessica C.; Becker, Juergen; Hauschild, Axel; Dummer, Reinhard"]},"id":{"doi":["10.1016/j.ejca.2013.09.014"],"eki":["1485234352"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"part":{"volume":"50","text":"50(2014), 2, Seite 406-410","year":"2014","issue":"2","extent":"5","pages":"406-410"},"language":["eng"],"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"pubHistory":["28.1992 -"],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"id":{"zdb":["1468190-0"],"issn":["1879-0852"],"eki":["266883400"]},"disp":"Upstream mitogen-activated protein kinase (MAPK)pathway inhibition MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsEuropean journal of cancer","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"EJC online"}],"origin":[{"dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press","dateIssuedDisp":"1992-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]"}],"recId":"266883400"}],"note":["Gesehen am 08.10.2014"],"recId":"1485234352","origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Upstream mitogen-activated protein kinase (MAPK)pathway inhibition","subtitle":"MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients","title":"Upstream mitogen-activated protein kinase (MAPK)pathway inhibition"}],"language":["eng"]} 
SRT |a UPSTREAMMI2014